You are here: EnoGene Home > Anti-inflammation new drug screening models > Anti-inflammation new drug screening models of EnoGene

Anti-inflammation new drug screening models of EnoGene

Anti-inflammation new drug screening models of EnoGene

 

Anti-hepatitis new drug screening models

  • Rat hepatitis model induced by D-galactosamine (D-Gal)
  • Mouse hepatitis model induced by concanavalin A (Con A)
  • Mouse hepatitis model induced by carbon tetrachloride (CCl4)

 

Anti- nephritis new drug screening models

  • Rat nephrotic syndrome model induced by adriamycin (ADR)
  • Rat progressive passive Heymann nephritis model (ppHN)
  • Rat nephrotic model induced by bovine serum albumin (BSA)
  • Rat active Heymann nephritis (AHN) model established by injecting i.p. renal cortex homogenate and Freund ' s complete adjuvant

 

Anti-arthritic new drug screening models

  • Rat arthritis model induced by Freund's complete adjuvant(CFA)
  • Rat arthritis model induced by type II collagen
  • Anti-pneumonia drug screening model
  • Mouse pneumonia model induced by lipopolysaccharide (LPS)
  • Immunomodulatory drug screening models

 

Features:

  • The experienced technicians can complete the projects in the shortest time.
  • Provide the most reliable and comprehensive data timely during the experiments.
  • Guarantee the model stable and reliable by biochemical test and pathological examination during the model establishment.
  • Evaluate more objectively the effect of drugs by quantitative analysis of the pathological injury score.
  • Help the clients to further study the drug mechanisam by providing the services of relevant WB, IHC, ELISA and cytokine analysis.

 

Successful Case

  • EnoGene successfully completed a project of 16 anti-hepatitis drugs activity screening and succeeded in obtaining 1 candidate drug which was confirmed to develop further preclinical research.